Palantir CEO says fentanyl response would be different 'if 60,000 Yale grads' were dying instead

Palantir CEO Alex Karp weighed in on the Trump administration's efforts to stop the flow of drugs into the U.S. and said that he supports the anti-drug campaign and sees elitism in the criticism of it.Karp spoke on Palantir's earnings call Monday after the tech company posted quarterly results that beat analysts' estimates on strong demand for artificial intelligence (AI) solutions. He went on to discuss the administration's campaign to crack down on the smuggling of fentanyl into the country."Let me say something slightly political, and I'm not saying other people agree with this," Karp said.